H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 26 700 KRW -0.93% Market Closed
Market Cap: 319.9B KRW

Net Margin
Huons Co Ltd

5.9%
Current
6%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.9%
=
Net Income
35.8B
/
Revenue
602.2B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
KR
Huons Co Ltd
KOSDAQ:243070
311.1B KRW
6%
US
Eli Lilly and Co
NYSE:LLY
1.1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
500.7B USD
27%
CH
Roche Holding AG
SIX:ROG
269.6B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
221.5B GBP
16%
CH
Novartis AG
SIX:NOVN
219.5B CHF
26%
US
Merck & Co Inc
NYSE:MRK
277.7B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
-126%
US
Pfizer Inc
NYSE:PFE
144.7B USD
16%
No Stocks Found

Huons Co Ltd
Glance View

Market Cap
311.1B KRW
Industry
Pharmaceuticals

Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.

Intrinsic Value
38 130.22 KRW
Undervaluation 30%
Intrinsic Value
Price
H
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.9%
=
Net Income
35.8B
/
Revenue
602.2B
What is the Net Margin of Huons Co Ltd?

Based on Huons Co Ltd's most recent financial statements, the company has Net Margin of 5.9%.

Back to Top